Elder Pharmaceuticals Ltd (ELDP.NS)

ELDP.NS on National Stock Exchange of India

226.45INR
3:04pm IST
Price Change (% chg)

Rs-3.65 (-1.59%)
Prev Close
Rs230.10
Open
Rs229.30
Day's High
Rs232.90
Day's Low
Rs224.10
Volume
45,855
Avg. Vol
145,547
52-wk High
Rs393.00
52-wk Low
Rs180.00

ELDP.NS

Chart for ELDP.NS

About

Elder Pharmaceuticals Ltd is primarily engaged and deals in pharmaceuticals and related products. The Company has operations in the women's healthcare, wound care and nutraceutical segments, and lifestyle disease management segment, as well as anti-infective segment. In addition to the formulation business, the Company offers... (more)
No analyst recommendations are available for ELDP.NS.

Overall

Beta: 0.47
Market Cap (Mil.): Rs4,725.55
Shares Outstanding (Mil.): 20.54
Dividend: --
Yield (%): --

Financials

  ELDP.NS Industry Sector
P/E (TTM): 250.06 32.71 32.86
EPS (TTM): 0.92 -- --
ROI: -- 19.60 18.86
ROE: -- 20.30 19.62
Search Stocks

MARKET EYE-Elder Pharma falls on worry about residual business

* Shares in Elder Pharmaceuticals Ltd slump 7 percent after rival Torrent Pharmaceuticals Ltd agreed to buy its branded formulations business in India and Nepal for about 20 billion rupees ($324.1 million). * Analysts tracking the sector say Elder is now left with only low-margin active pharmaceutical ingredient and European businesses which will be assigned a lower valuation multiple. * "Brands which are growth-oriented and contributed significantly to profits have been transferred to Torrent

13 Dec 2013

Torrent Pharma buys Elder's India formulations business for $324 million

MUMBAI - Torrent Pharmaceuticals agreed to buy branded formulations business of rival Elder Pharmaceuticals in India and Nepal for about 20 billion rupees to boost its market share.

13 Dec 2013

Torrent Pharma buys Elder's India formulations biz for $324 million

MUMBAI - India's Torrent Pharmaceuticals Ltd agreed to buy branded formulations business of rival Elder Pharmaceuticals Ltd in India and Nepal for about 20 billion rupees ($324.1 million) to boost its market share.

13 Dec 2013

Torrent Pharma buys Elder's India formulations biz for $324 mln

MUMBAI, Dec 13 - India's Torrent Pharmaceuticals Ltd agreed to buy branded formulations business of rival Elder Pharmaceuticals Ltd in India and Nepal for about 20 billion rupees ($324.1 million) to boost its market share.

13 Dec 2013

Torrent Pharma in race for part of Elder Pharmaceuticals

Ahmedabad-based drugmaker Torrent Pharmaceuticals Ltd has submitted a non-exclusive bid to acquire certain businesses of Elder Pharmaceuticals Ltd, it disclosed on Friday.

25 Nov 2013

Earnings vs. Estimates

Search Stocks